Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The particular peptides that now reside on the FDAs Category 2 Bulk Substances list never met the criteria for compounding, yet some pharmacies had been supplying them anyway to patients with a physicians prescription
Rankings reflect the editorial judgment of our research team and are not an endorsement or guarantee of services
In a Bank of America note published on Monday, the analyst argues that brand mail pharmacy margins can be 5-10% (and in many cases pharmacies are losing money on GLP-1 scripts), which are significantly lower than the 50% gross margins we estimate HIMS is capturing in its GLP-1 portfolio. It is unlikely that HIMS will follow Ros lead to partner with brand manufacturers, the analyst added, because HIMS differentiation and success is tied to its own brand equity for its products and selling branded pharmaceutical drugs would both hurt margins and cannibalize its core products. Diversifying Beyond the Major GLP-1 Drugs Hims could also look to broaden its weight loss offerings, leveraging its established telehealth platform to incorporate non-drug-based solutions
However, a wide range of non-surgical and surgical treatments offer effective solutions
Alongside its use for weight loss, Retatrutide is also being studied as a possible treatment for type 2 diabetes
US$ 24.86
US$ 21.39
US$ 29.89
:format(webp))
US$ 26.25
